NeuroMET2 - Metrologie und Innovation zur Früherkennung und genauen Stratifizierung von Patienten mit neurodegenerativen Erkrankungen



Short title: NeuroMET2

Investigated disease: AD

Principal Investigator: Laura Göschel


Clinic, Institute: Klinik für Neurologie CCM

Patient (diseased)

Status: Participants wanted
Last change: 26.09.2020

Back to Overview



You are here:

Study Description

Title

NeuroMET2 - Metrologie und Innovation zur Früherkennung und genauen Stratifizierung von Patienten mit neurodegenerativen Erkrankungen

Short title

NeuroMET2

Scientific Short Description

This project will metrologically address the challenges associated with diagnosis of AD by building upon the results of the preceding EMPIR 15HLT04 NeuroMET project and its unique patient cohort. The most promising NeuroMET minimally invasive methods for early diagnosis of AD will be advanced through longitudinal studies and transfered into clinical settings. The project will also lead to the development of novel approaches and reference measurement procedures that will address the current measurement challenges for early NDD diagnostics and therapies.

Investigated Disease, Health Issue

ICD-Code
  • F00 - Demenz bei Alzheimer-Krankheit

Characteristics

Studytype

Non-interventional

Studyphase

N/A

Back to Overview